Mingzhi Zhang

机构：Soochow University, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0001-8428-6090

发表论文 199 篇 · 总被引 3248 次 · h-index 30

代表论文

• Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (2025 · Nature Cancer · 被引 52)
• Butyrate-producing Faecalibacterium prausnitzii suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathway (2024 · Gut · 被引 49)
• Faecalibacterium prausnitzii promotes anti-PD-L1 efficacy in natural killer/T-cell lymphoma by enhancing antitumor immunity (2025 · BMC Medicine · 被引 14)
• How do built environment factors influence urban heat islands across local climate zones? Evidence from an interpretable XGBoost-SHAP model (2025 · Sustainable Cities and Society · 被引 13)
• Clinical features and prognostic factors of intravascular large B-cell lymphoma: a cohort study of 20 patients from 2018 to 2024 (2025 · The Oncologist · 被引 5)
• A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma (2025 · Journal of Hematology & Oncology · 被引 5)